Navigation Links
Alimera Reports Results From the Six-Month Interim Readout of the Human PK Iluvien(TM) Study
Date:10/1/2008

20 percent at the three-month readout to 10 percent because one patient developed a cataract and one patient developed an epiretinal membrane involving the macula prior to the readout. The development of cataracts and epiretinal membranes in a diabetic population are not unusual and are commonly addressed with surgical intervention.

In addition, the six-month readout showed 25 percent of the low dose patients and 41 percent of the high dose patients had an improvement in BCVA of 10 letters or greater from baseline. This is an improvement from the three-month data where 20 percent of low dose patients and 29 percent of high dose patients had gained more than 10 letters compared to baseline.

"It is very encouraging that the number of patients with greater than 10-letter improvement has increased for both doses when comparing the six- month data to the three-month data," said Ken Green, Ph.D., chief scientific officer of Alimera.

From a safety perspective, no adverse events related to intraocular, or inner eye, pressure were seen in the low dose patients, while 12 percent of the high dose patients experienced intraocular pressure increases of 30 mmHg or greater at some time point. Further, 10 percent of the low dose patients and 12 percent of the high dose patients reported an adverse event related to cataract formation, and one additional patient in each dose group underwent a cataract extraction.

"The six-month readout from the Iluvien PK study continues to support the premise that corticosteroids, delivered in low doses in a consistent and sustained manner directly into posterior segment of the eye, can be an efficacious treatment for DME," said Dan Myers, president and CEO of Alimera Sciences, "We are also pleased with Iluvien's safety profile as evidenced by the low IOP rates and the lack of filtration procedures at the month 6 time point."

Data from the PK Study will continue to be evaluated with interim looks at months 12, 18,
'/>"/>

SOURCE Alimera Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. DSMB Again Supports Continuation of Alimera Sciences Phase 3 Clinical Trial of Iluvien(TM) for the Treatment of DME
2. Alimera Reports Results From the Three-Month Interim Readout of the Human PK Medidur(TM) FA Study
3. BioView Reports Interim Results of Early Detection Lung Cancer Diagnostic Test
4. Bioheart Reports Promising Results From Preclinical Study of Adipose-Derived Acute Cell Therapy
5. MannKind Reports Positive Data from a Phase 3 Clinical Study of Technosphere Insulin in Type 1 Diabetes
6. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
7. Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate
8. Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma
9. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
10. Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin
11. Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... SAN DIEGO , July 2, 2015 ResMed ... report its fourth quarter and fiscal year ended June 30, ... York Stock Exchange market close. A press release with ResMed,s ... and the company will host a webcast to discuss operating ... scheduled to begin at 1:30 p.m. US Pacific Time and ...
(Date:7/2/2015)... 2, 2015  Before you head outdoors with your family ... stay safe and healthy. Take steps to protect yourself from ... Protect Your Skin From the Sun ... increase your risk of skin cancer. To protect your skin ... possible, especially during midday hours. Wear a hat with a ...
(Date:7/2/2015)... According to a new market research report " ... Stimulation, Transcranial Magnetic Stimulation), Application (Depression, Parkinson,s, Tinnitus, Alzheimer,s, Epilepsy, ... MarketsandMarkets, the global Neuromodulation Market is estimated at $3.65 Billion ... 2020, at a CAGR of 11.2% during the forecast period. ... market data T ables and 32 ...
Breaking Medicine Technology:ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2First Aid Summer Survival Tips from Nyack Hospital 2First Aid Summer Survival Tips from Nyack Hospital 3Neuromodulation Market Worth $6.20 Billion by 2020 2Neuromodulation Market Worth $6.20 Billion by 2020 3Neuromodulation Market Worth $6.20 Billion by 2020 4
... Phase 1,clinical trial results for NKTR-118 (oral PEG-naloxol) were ... at the Annual Meeting of the,American Pain Society (APS) ... NKTR-118 was shown to have substantial oral bioavailability,with rapid ... ten times the,known half-life of unPEGylated naloxone., NKTR-118 ...
... Shows Benefits Differ from those in Adults-, ... are hospitalized for bacterial meningitis do not provide ... according to a large,multicenter study by pediatric researchers. ... hospitalized adults, for whom corticosteroids,dramatically reduced mortality., ...
Cached Medicine Technology:NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 2NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 3NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 4NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 5NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 6Steroids Provide No Survival Benefit for Children With Bacterial Meningitis 2Steroids Provide No Survival Benefit for Children With Bacterial Meningitis 3
(Date:7/4/2015)... ... July 05, 2015 , ... Dating a real millionaire online ... best online millionaire dating service and strives to remove the worries from meeting partners. ... millionaire dating app of 2015 and readers have responded with excitement. ...
(Date:7/4/2015)... ... July 04, 2015 , ... Tyler Boden, Project Developer ... sales expertise from the North American Board of Certified Energy Practitioners (NABCEP®), and ... highly respected and well established national certification organization for renewable energy professionals. Designation ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... lineup for its 2015 Annual Conference , the premiere continuing education ... the Renaissance Orlando at SeaWorld in Orlando, Florida. Speakers include the leading ...
(Date:7/3/2015)... ... 03, 2015 , ... B. E. Smith, the only full-service ... a national chief nursing officer recruitment for Jane Phillips Medical Center ... industry, B. E. Smith has recently placed more than 1,000 healthcare executives into ...
(Date:7/3/2015)... ... July 03, 2015 , ... Jennifer Renee Hanes, DO is the new Medical ... largest network of independent freestanding emergency rooms in the United States. , “We are ... Plantation facility,” said Executive Medical Director of First Choice Emergency Room, Dr. James M. ...
Breaking Medicine News(10 mins):Health News:MillionaireMatchapp.com Publishes the Best Millionaire Dating App and Official Dating Site Reviews 2015 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3
... UNION CITY, Calif., July 23 Abaxis, Inc. (Nasdaq: ... has scheduled a conference call to discuss its financial results for the ... will be at 4:15 p.m. ET on Thursday, July 30, 2009. , ... (412) 858-4600 to access the conference call, or can listen via a ...
... , , , , ... today reported results for the 2009 second quarter and first half ended June ... 2009 second quarter and decreased 5% to $11.1 billion for the 2009 first ... 2% for the 2009 second quarter and first half. , ...
... , The 10th Annual Conference and Exposition of the ... Human Resource Management --HR: Building Bridges to Success" in ... July 23-24 , , DEKALB, ... wellness programs that help workers lose weight or quit smoking, for instance, also create ...
... July 23 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc.,(Nasdaq: SSRX ... manufacturing and marketing biopharmaceutical,products, today announced that it will ... 2009 after the US market closes on Tuesday,August 11, ... announcement, 3SBio,s senior management will host a,conference call at ...
... ... Raleigh NC dentist Dr. Robert L. Williamson one of America,s Top Dentists. , ... Raleigh, North Carolina (PRWEB) July 23, 2009 ... received an award for being one of the top dentists in the United States. The ...
... the banking and,healthcare software group, reported continued growth despite the turmoil ... results have been boosted by a market beating,performance at its Allscripts/Misys ... In a video interview, CEO Mike Lawrie conceded there are some ... "We did not close some of the ...
Cached Medicine News:Health News:Abaxis to Report First Quarter Fiscal 2010 Financial Results Thursday, July 30, 2009 2Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 2Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 3Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 4Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 5Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 6Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 7Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 8Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 9Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 10Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 11Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 12Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 13Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 14Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 15Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 16Health News:Employee Wellness Programs Demonstrate Positive Return on Investment for Businesses 2Health News:Employee Wellness Programs Demonstrate Positive Return on Investment for Businesses 3Health News:3SBio Inc. to Report 2009 Second Quarter Earnings on August 11, 2009 2Health News:3SBio Inc. to Report 2009 Second Quarter Earnings on August 11, 2009 3Health News:Dr. Robert L. Williamson III Once Again Selected As One of America's Top Dentists 2
... Professional Diagnostics is a leading provider of ... DFA test menu that includes kits for ... well as miscellaneous conjugates and components. Our ... wide assortment of substrates and kit sizes ...
... ELISA products make us a leader in ... faster integration into the busy laboratory, our ... and run-to-run consistency. Our Infectious Disease ELISA ... wide range of serological assays including ToRCH, ...
... of infectious disease ELISA products make us ... assay protocols for faster integration into the ... provide increased reliability and run-to-run consistency. Our ... assays for a wide range of serological ...
... disease ELISA products make us a leader ... for faster integration into the busy laboratory, ... reliability and run-to-run consistency. Our Infectious Disease ... a wide range of serological assays including ...
Medicine Products: